Allergen-induced generation of mediators in the mucosa.
The inhalation of antigens does not normally lead to allergic inflammation, but airway resident cells and their products may affect the outcome of antigen exposure. It is therefore important to elucidate how potential allergens interact with airway epithelial cells and other cells located within and below the epithelium. Some studies have indicated that certain antigens, particularly the major house dust mite antigen Der p1, penetrate the airway epithelium by intracellular transportation or paracellular passage, depending on their concentrations, time of exposure, and ability of the cells to inactivate them. If an antigen possesses proteolytic activity, such as Der p1, and it reaches high concentrations or the exposure is prolonged, the disruption of the tight junction can also favor the transepithelial passage of other antigens. In this way, the antigens can easily encounter the effector cells located between epithelial cells and below the basement membrane. The magnitude of this phenomenon may be more prominent in the airways of asthmatic patients, as their epithelium is more permeable to Der p1 than the epithelium of nonasthmatic patients and releases cytokines after exposure to very low concentrations of this antigen for brief periods. Epithelial cell activation may facilitate the development of allergic mucosal sensitization to Der p1 and contribute to the antigen-induced inflammatory response by affecting the migration and function of dendritic cells, mast cells, and eosinophils. Also, there might be a secondary release of interleukin-6 and endothelin-1, which can have a detrimental effect on the cardiovascular function.
Mattoli
S
S
Avail Biomedical Research Institute, Basel, Switzerland. smattoli@avail-research.com
D000485:Allergens / Q000009:adverse effects*; D039741:Antigens, Dermatophagoides; D001249:Asthma / Q000139:chemically induced / Q000276:immunology*; D001980:Bronchi / Q000276:immunology; D004847:Epithelial Cells / Q000187:drug effects / Q000276:immunology; D006023:Glycoproteins / Q000009:adverse effects*; D006801:Humans; D020545:Respiratory Mucosa / Q000187:drug effects / Q000276:immunology*
D000485:Allergens; D039741:Antigens, Dermatophagoides; D006023:Glycoproteins